Skip to content

Vinbrain Joint Stock Company

VietnamFDA applicant, unverified

Devices
2

What Vinbrain Joint Stock Company makes

Vinbrain produces AI-assisted medical imaging software tools, including DrAid for Radiology v1 and DrAid for Liver Segmentation, designed to assist radiologists in analyzing and segmenting medical images for diagnostic purposes.

The company’s portfolio is regulated under FDA 510(k) clearance as Class II devices and is listed in the FDA’s 510(k) database. Vinbrain is headquartered in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • DrAid for Radiology v1 Ref K221241

    Active Regimes: 510(k) Registry: 510(k) Class:II
  • DrAid™ for Liver Segmentation Ref K241543

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Vinbrain Joint Stock Company have in the registry?

The registry currently lists 2 devices for Vinbrain Joint Stock Company. Devices recorded under merged duplicate company entries are counted once.

Which registries list Vinbrain Joint Stock Company's devices?

Among its 2 most recently registered devices, Vinbrain Joint Stock Company has devices listed in FDA 510(k) (2 devices).

What risk classes do Vinbrain Joint Stock Company's devices fall under?

Among its 2 most recently registered devices, the classes recorded for Vinbrain Joint Stock Company's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Vinbrain Joint Stock Company in the registry?

The most recently registered devices listed for Vinbrain Joint Stock Company include DrAid for Radiology v1 and DrAid™ for Liver Segmentation.

Generated automatically from registry data and not verified by a human reviewer.